×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Digital Diabetes Management Market

ID: MRFR/HC/48846-HCR
200 Pages
Garvit Vyas
October 2025

South Korea Digital Diabetes Management Market Research Report By Technology (Mobile Applications, Wearable Devices, Remote Monitoring Solutions, Telehealth Services), By Product Type (Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, Diabetes Management Software), By End-user (Patients, Healthcare Professionals, Pharmacies, Diabetes Care Centers), andBy Functionality (Data Management, Patient Engagement, Clinical Decision Support, Remote Patient Monitoring)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South Korea Digital Diabetes Management Market Infographic
Purchase Options

South Korea Digital Diabetes Management Market Summary

As per MRFR analysis, the South Korea digital diabetes-management market size was estimated at 135.75 USD Million in 2024. The South Korea digital diabetes-management market is projected to grow from 152.83 USD Million in 2025 to 500.04 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 12.58% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The South Korea The digital diabetes-management market is experiencing robust growth. This growth is driven by technological advancements and increasing health awareness.

  • The market is witnessing a rise in mobile health applications, enhancing patient engagement and self-management.
  • Integration of wearable technology is becoming prevalent, allowing for real-time monitoring of glucose levels.
  • Telehealth services are expanding, providing patients with convenient access to healthcare professionals.
  • The increasing prevalence of diabetes and government initiatives are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 135.75 (USD Million)
2035 Market Size 500.04 (USD Million)

Major Players

Abbott (US), Medtronic (US), Roche (CH), Dexcom (US), Ascensia Diabetes Care (DE), Insulet Corporation (US), Tandem Diabetes Care (US), Glooko (US)

South Korea Digital Diabetes Management Market Trends

The digital diabetes-management market in South Korea is experiencing notable growth. This growth is driven by increasing awareness of diabetes and the rising prevalence of the condition among the population. The integration of technology into healthcare has led to the development of innovative solutions that assist individuals in managing their diabetes more effectively. Mobile applications, wearable devices, and telehealth services are becoming essential tools for patients, enabling them to monitor their blood glucose levels, track dietary habits, and communicate with healthcare professionals seamlessly. This shift towards digital solutions reflects a broader trend in healthcare, where convenience and accessibility are prioritized. Moreover, the South Korean government is actively promoting digital health initiatives, which further supports the expansion of the digital diabetes-management market. Policies aimed at enhancing healthcare technology infrastructure and encouraging the adoption of digital health tools are being implemented. As a result, healthcare providers are increasingly adopting these technologies to improve patient outcomes and streamline care processes. The combination of technological advancements and supportive government policies suggests a promising future for the digital diabetes-management market in South Korea. It continues to evolve and adapt to the needs of patients and healthcare providers alike.

Rise of Mobile Health Applications

Mobile health applications are becoming increasingly popular in the digital diabetes-management market. These applications provide users with tools to monitor their glucose levels, manage medication schedules, and receive personalized dietary recommendations. The convenience of having health management tools readily available on smartphones encourages more individuals to engage actively in their diabetes care.

Integration of Wearable Technology

Wearable technology is playing a crucial role in the digital diabetes-management market. Devices such as smartwatches and continuous glucose monitors allow users to track their health metrics in real-time. This integration not only enhances self-management but also facilitates data sharing with healthcare providers, leading to more informed treatment decisions.

Telehealth Services Expansion

The expansion of telehealth services is transforming the digital diabetes-management market. Patients can now consult healthcare professionals remotely, reducing barriers to access and improving the continuity of care. This trend is particularly beneficial for individuals in rural areas, where healthcare resources may be limited.

South Korea Digital Diabetes Management Market Drivers

Increasing Prevalence of Diabetes

The rising incidence of diabetes in South Korea is a primary driver for the digital diabetes-management market. Recent statistics indicate that approximately 13.4% of the adult population is affected by diabetes, a figure that continues to grow. This alarming trend necessitates innovative management solutions, prompting healthcare providers and technology firms to invest in digital platforms. The digital diabetes-management market is expected to expand as patients seek effective tools for monitoring and controlling their condition. Moreover, the South Korean government has initiated various health campaigns aimed at diabetes awareness, further stimulating demand for digital solutions. As the population ages and lifestyle-related diabetes cases increase, the market is likely to see a surge in adoption of digital management tools, which could enhance patient outcomes and reduce healthcare costs.

Government Initiatives and Support

Government initiatives in South Korea play a crucial role in promoting the digital diabetes-management market. The Ministry of Health and Welfare has launched several programs aimed at integrating technology into diabetes care, including subsidies for digital health solutions. These initiatives not only encourage the development of innovative applications but also facilitate access for patients. For instance, the government has allocated approximately $50 million to support research and development in digital health technologies. Such financial backing is likely to foster collaboration between tech companies and healthcare providers, enhancing the overall ecosystem. As a result, the digital diabetes-management market is poised for growth, with increased investment leading to more effective and user-friendly solutions for diabetes management.

Rising Health Awareness Among Consumers

There is a notable increase in health awareness among South Korean consumers, which significantly impacts the digital diabetes-management market. As individuals become more informed about the risks associated with diabetes, they are actively seeking tools to manage their health. This shift in consumer behavior is reflected in the growing demand for mobile applications and digital platforms that offer personalized health insights. Market data suggests that the adoption rate of health-related apps has surged by over 30% in the past year. This trend indicates a strong willingness among consumers to embrace technology for health management. Consequently, the digital diabetes-management market is likely to benefit from this heightened awareness, as more individuals turn to digital solutions for effective diabetes control.

Technological Advancements in Healthcare

Technological advancements are transforming the healthcare landscape in South Korea, thereby driving the digital diabetes-management market. Innovations such as artificial intelligence, machine learning, and data analytics are being integrated into diabetes management solutions, enhancing their effectiveness. For instance, AI-driven applications can analyze patient data to provide personalized recommendations, improving adherence to treatment plans. The market is witnessing a surge in the development of smart devices that connect with mobile applications, allowing for real-time monitoring of blood glucose levels. This integration of technology not only empowers patients but also enables healthcare providers to offer more tailored care. As these advancements continue to evolve, the digital diabetes-management market is expected to expand, offering more sophisticated tools for diabetes management.

Growing Demand for Remote Patient Monitoring

The demand for remote patient monitoring solutions is escalating in South Korea, significantly influencing the digital diabetes-management market. With the increasing prevalence of chronic diseases, healthcare providers are seeking efficient ways to monitor patients outside traditional clinical settings. Digital tools that facilitate remote monitoring allow for continuous tracking of blood glucose levels and other vital signs, enabling timely interventions. Recent surveys indicate that over 60% of healthcare professionals support the use of digital solutions for managing diabetes remotely. This trend is likely to drive the adoption of digital diabetes-management tools, as both patients and providers recognize the benefits of proactive health management. Consequently, the market is expected to grow as more healthcare systems integrate remote monitoring capabilities into their diabetes care protocols.

Market Segment Insights

By Technology: Glucose Monitoring Devices (Largest) vs. Diabetes Management Software (Fastest-Growing)

In the South Korea digital diabetes-management market, Glucose Monitoring Devices hold the largest share, showing a significant preference among users due to their critical role in managing glucose levels. On the other hand, Diabetes Management Software is rapidly gaining traction, reflecting the ongoing shift towards more integrated digital solutions for diabetes care. The growth in these segments is driven by increasing awareness of diabetes management and advancements in technology. Glucose Monitoring Devices benefit from innovations like continuous glucose monitoring, while Diabetes Management Software thrives on enhanced data analytics and accessibility through various platforms. Additionally, mobile applications are supplementing these devices, creating a comprehensive ecosystem for diabetes management.

Technology: Glucose Monitoring Devices (Dominant) vs. Diabetes Management Software (Emerging)

Glucose Monitoring Devices dominate the South Korea digital diabetes-management market due to their essential function in real-time monitoring of blood glucose levels, leading to better health outcomes for users. These devices have evolved with features like smartphone integration and cloud data storage, allowing for seamless tracking and sharing of information. On the other hand, Diabetes Management Software has emerged as an innovative tool, providing personalized insights and analytics that enhance diabetes care. This software is becoming increasingly popular as users seek more sophisticated ways to manage their condition, making it a vital component of the digital health landscape in South Korea.

By Product Type: Continuous Glucose Monitors (Largest) vs. Smart Insulin Pens (Fastest-Growing)

The South Korea digital diabetes-management market exhibits a diverse product landscape, with Continuous Glucose Monitors holding the largest market share. These devices have gained significant traction among users due to their ability to provide real-time glucose readings, which facilitate better diabetes management. Smart Insulin Pens are also notable, rapidly increasing their presence as more individuals recognize their advantages, including dosage precision and ease of use in daily routines. Growth trends within this segment show a consistent rise driven by technological advancements and increasing awareness of diabetes care among the population. The proliferation of Diabetes Management Platforms and Wearable Devices is also shaping the market dynamics by integrating lifestyle monitoring with glucose control, leading to improved health outcomes. This integration is enhancing user engagement and satisfaction, propelling further adoption across various demographics.

Continuous Glucose Monitors (Dominant) vs. Smart Insulin Pens (Emerging)

Continuous Glucose Monitors stand out as the dominant force within the South Korea digital diabetes-management market due to their comprehensive capabilities, offering continuous tracking and alert systems that empower users to manage their glucose levels effectively. In contrast, Smart Insulin Pens represent an emerging segment that is rapidly gaining attention for their innovative features such as Bluetooth connectivity and automatic dose calculation, which appeal particularly to tech-savvy users. Together, these products create a robust ecosystem, enhancing the overall diabetes management experience by combining real-time monitoring with precise medication delivery. As awareness grows, the demand for both product categories is expected to rise, fostering a more proactive approach to diabetes care.

By End User: Individuals (Largest) vs. Healthcare Providers (Fastest-Growing)

Within the South Korea digital diabetes-management market, the distribution among user segments showcases Individuals as the largest end user group, holding a significant proportion of the market share. Healthcare Providers follow as a crucial segment, facilitating patient care and adopting technologies that enhance their services. Pharmaceutical Companies and Research Organizations, although integral to the ecosystem, currently hold a smaller share in comparison to these primary groups, indicating a skew towards direct consumer engagement in the market. As the market evolves, growth trends are predominantly driven by the increasing prevalence of diabetes among Individuals, which drives demand for digital management solutions. The commitment of Healthcare Providers to integrate these solutions into their practices is emerging as a key growth factor, particularly as they seek to improve patient outcomes and engagement. Hence, the emphasis on accessible, easy-to-use digital solutions is attracting attention in the healthcare sector, making Providers the fastest-growing segment.

Individuals (Dominant) vs. Pharmaceutical Companies (Emerging)

Individuals in the South Korea digital diabetes-management market represent a dominant force, leveraging digital tools for personal health management and monitoring. Their access to and engagement with these solutions create a robust demand for innovative products tailored to individual needs. In contrast, Pharmaceutical Companies are identified as an emerging segment, increasingly recognizing the necessity to provide digital healthcare solutions alongside their medicinal products. They are making strategic investments to enhance their digital offerings, aiming to integrate with personal diabetes management tools and create synergies between medication and digital health applications, thus positioning themselves to meet the changing expectations of patients and healthcare professionals alike.

By Distribution Channel: Online Sales (Largest) vs. Pharmacies (Fastest-Growing)

In the South Korea digital diabetes-management market, the distribution of sales across channels reveals that online sales maintain the largest share, driven by increasing consumer preference for convenience and the rise of e-commerce platforms. Pharmacies represent a significant portion of the market as well, serving as accessible points for diabetes management products and services. The growth trends in this segment highlight a robust shift towards online sales as consumers exhibit a growing inclination to purchase diabetes management solutions through digital platforms. Pharmacies are emerging as the fastest-growing channel, fueled by their expanding role in healthcare delivery and the increasing integration of diabetes management solutions into pharmacy services.

Online Sales (Dominant) vs. Pharmacies (Emerging)

Online sales have established themselves as the dominant channel for diabetes management products, characterized by their extensive reach and convenience for patients seeking timely solutions. The ease of access to information and products online enhances user engagement while fostering a preference for digital transactions. Conversely, pharmacies are considered an emerging channel, reflecting their ability to adapt to consumer needs through personalized service and professional advice. The integration of technology within pharmacies, such as telepharmacy and online prescription services, positions them to capitalize on the growing demand for diabetes management, thereby increasing their market relevance.

Get more detailed insights about South Korea Digital Diabetes Management Market

Key Players and Competitive Insights

The digital diabetes-management market in South Korea is characterized by a dynamic competitive landscape, driven by technological advancements and increasing prevalence of diabetes. Key players such as Abbott (US), Medtronic (US), and Dexcom (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Abbott (US) has positioned itself as a leader in continuous glucose monitoring (CGM) technology, while Medtronic (US) emphasizes integrated diabetes management solutions. Dexcom (US) continues to innovate with its CGM systems, enhancing user experience and data integration capabilities. Collectively, these strategies foster a competitive environment that prioritizes technological innovation and user-centric solutions.

In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for diverse offerings and competitive pricing, yet the influence of major companies remains significant, shaping market trends and consumer preferences.

In October 2025, Abbott (US) announced the launch of its latest CGM system, which integrates advanced AI algorithms to provide real-time insights and predictive analytics for users. This strategic move is likely to enhance patient engagement and adherence to diabetes management protocols, positioning Abbott as a frontrunner in the digital diabetes space. The integration of AI into their product line suggests a commitment to leveraging technology for improved health outcomes.

In September 2025, Medtronic (US) expanded its partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This collaboration aims to streamline diabetes management for patients, particularly in rural areas, where access to healthcare may be limited. By integrating telehealth solutions, Medtronic is likely to improve patient outcomes and expand its reach in the South Korean market.

In August 2025, Dexcom (US) launched a new feature in its CGM app that allows users to share glucose data with healthcare providers in real-time. This strategic enhancement not only improves communication between patients and providers but also positions Dexcom as a leader in patient-centric diabetes management solutions. The ability to share data seamlessly could lead to more personalized treatment plans and better health outcomes.

As of November 2025, current trends in the digital diabetes-management market include a strong emphasis on digitalization, sustainability, and AI integration. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and enhancing service delivery. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on technological innovation, user experience, and supply chain reliability. Companies that prioritize these aspects are likely to gain a competitive edge in the increasingly complex market.

Key Companies in the South Korea Digital Diabetes Management Market market include

Industry Developments

The South Korea Digital Diabetes Management Market has seen significant developments recently, particularly with advancements in technology and strategic partnerships among major players.

In October 2023, LG Electronics announced an initiative to enhance its diabetes management solutions through collaborations with healthcare professionals aimed at improving patient engagement and outcomes. Concurrently, Abbott Diabetes Care launched a new version of their continuous glucose monitoring system tailored for South Korean consumers, reflecting the rising demand for innovative solutions.

Over the past couple of years, Glooko gained traction with its holistic diabetes management platform, integrating seamlessly with various diabetes devices, which has broadened its reach among healthcare providers in South Korea. 

In June 2023, the South Korean government also increased funding for diabetes management initiatives, further fostering growth in the sector.

Companies like Medtronic and Dexcom continue to invest in Research and Development, enhancing their product offerings to meet local market needs effectively. While there have not been publicly reported mergers or acquisitions among the major companies in this period, the market's overall valuation continues to rise, driven by an increasing prevalence of diabetes and a growing emphasis on digital health solutions.

Future Outlook

South Korea Digital Diabetes Management Market Future Outlook

The Digital Diabetes Management Market is projected to grow at a 12.58% CAGR from 2024 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising health awareness.

New opportunities lie in:

  • Development of AI-driven predictive analytics tools for personalized diabetes management.
  • Expansion of telehealth services to enhance patient engagement and monitoring.
  • Integration of wearable devices with mobile applications for real-time data tracking.

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased consumer adoption.

Market Segmentation

South Korea Digital Diabetes Management Market End User Outlook

  • Individuals
  • Healthcare Providers
  • Pharmaceutical Companies
  • Research Organizations

South Korea Digital Diabetes Management Market Technology Outlook

  • Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Diabetes Management Software
  • Mobile Applications

South Korea Digital Diabetes Management Market Product Type Outlook

  • Continuous Glucose Monitors
  • Smart Insulin Pens
  • Diabetes Management Platforms
  • Wearable Devices

South Korea Digital Diabetes Management Market Distribution Channel Outlook

  • Online Sales
  • Pharmacies
  • Hospitals
  • Specialized Diabetes Clinics

Report Scope

MARKET SIZE 2024 135.75(USD Million)
MARKET SIZE 2025 152.83(USD Million)
MARKET SIZE 2035 500.04(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 12.58% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Abbott (US), Medtronic (US), Roche (CH), Dexcom (US), Ascensia Diabetes Care (DE), Insulet Corporation (US), Tandem Diabetes Care (US), Glooko (US)
Segments Covered Technology, Product Type, End User, Distribution Channel
Key Market Opportunities Integration of artificial intelligence in digital diabetes-management market enhances personalized patient care and treatment adherence.
Key Market Dynamics Rising adoption of mobile health applications enhances patient engagement in digital diabetes-management solutions.
Countries Covered South Korea

Leave a Comment

FAQs

What is the expected market size of the South Korea Digital Diabetes Management Market in 2024?

The South Korea Digital Diabetes Management Market is expected to be valued at 308.1 million USD in 2024.

What is the projected market size for the South Korea Digital Diabetes Management Market in 2035?

By 2035, the overall market is anticipated to reach 1,665.0 million USD.

What is the expected compound annual growth rate (CAGR) for the South Korea Digital Diabetes Management Market from 2025 to 2035?

The expected CAGR for the South Korea Digital Diabetes Management Market during the period from 2025 to 2035 is 16.577%.

What are the key technologies driving the South Korea Digital Diabetes Management Market?

The major technologies include Mobile Applications, Wearable Devices, Remote Monitoring Solutions, and Telehealth Services.

How much is the market for Mobile Applications projected to be in 2035?

The market for Mobile Applications is projected to reach 490.3 million USD by 2035.

Which key players are currently leading the South Korea Digital Diabetes Management Market?

Key players in the market include Bayer, Dexcom, Abbott Diabetes Care, and Johnson & Johnson.

What is the expected market value for Wearable Devices in 2024?

The expected market value for Wearable Devices in 2024 is 75.6 million USD.

What is the projected market size for Remote Monitoring Solutions in 2035?

Remote Monitoring Solutions are expected to reach a market size of 523.5 million USD by 2035.

What challenges does the South Korea Digital Diabetes Management Market face?

The market faces challenges including regulatory hurdles and the need for continuous innovation in technology.

How much is the market for Telehealth Services projected to be in 2035?

The market for Telehealth Services is projected to reach 251.0 million USD by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions